LFGAX | Focused Growth Fund Class A | Lord Abbett

Tracked Funds

You have 0 funds on your mutual fund watch list.

Begin by selecting funds to create a personalized watch list.

(as of 12/05/2015)

Pending Orders

You have 0 items in your cart.

Subscribe and order forms, fact sheets, presentations, and other documents that can help advisers grow their business.

 

Focused Growth Fund

Track this Fund
Add to Hypo Tool

Summary

Summary

What is the Focused Growth Fund?

The Fund seeks to deliver long-term growth of capital by investing primarily in stocks of U.S. companies.

Fund Basicsas of 01/31/2024

Total Net Assets
$47.64 M
Inception Date
02/01/2019
Dividend Frequency
Annually (Daily Accrual)
Fund Gross Expense Ratio
1.54%
Fund Net Expense Ratio
1.05%
Number of Holdings
32
Minimum Initial Investment
$1,500+

TEN LARGEST HOLDINGS as of 01/31/2024View Portfolio

Holding Assets
NVIDIA Corp 10.4%
Microsoft Corp 6.2%
Amazon.com Inc 5.4%
Shopify Inc 4.8%
Apple Inc 3.9%
Arista Networks Inc 3.9%
MercadoLibre Inc 3.5%
Alphabet Inc 3.5%
Meta Platforms Inc 3.4%
Netflix Inc 3.3%

INVESTMENT TEAM

F. Thomas O'Halloran
F. Thomas O'Halloran, CFA, J.D.

Partner, Portfolio Manager

36 Years of Industry Experience

Vernon Bice
Vernon Bice, CMT

Portfolio Manager

22 Years of Industry Experience

Matthew R. DeCicco
Matthew R. DeCicco, CFA

Partner & Director of Equities

23 Years of Industry Experience

Supported By 44 Investment Professionals with 17 Years Avg. Industry Experience

Your Representative

To contact your representative, enter your zip code and select your channel below.

Performance

Performance

Fund Expense Ratio :

Gross 1.54%

Net 1.05%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 01/31/2019
w/o sales charge 6.14% 32.38% -0.64% 16.04% - 16.04%
Lipper Category Avg. Large-Cap Growth Funds 3.15% 33.28% 6.87% 15.09% - -
Russell 1000® Growth Index 2.49% 34.99% 10.03% 18.04% - 18.04%
w/ sales charge 0.04% 24.77% -2.58% 14.67% - 14.67%

Fund Expense Ratio :

Gross 1.54%

Net 1.05%

Fund Expense Ratio :

Gross 1.54%

Net 1.05%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 01/31/2019
w/o sales charge 33.80% 33.80% -2.71% - - 14.94%
Lipper Category Avg. Large-Cap Growth Funds 40.51% 40.51% 5.34% - - -
Russell 1000® Growth Index 42.68% 42.68% 8.86% - - 17.79%
w/ sales charge 26.10% 26.10% -4.62% - - 13.55%

Fund Expense Ratio :

Gross 1.54%

Net 1.05%

Year Fund Returns Russell 1000® Growth Index
2023 33.80% 42.68%
2022 -39.06% -29.14%
2021 12.94% 27.60%
2020 86.10% 38.49%
2019 15.67% 36.39%
Year Q1 Q2 Q3 Q4 Yearly Returns
2024 - - - - 14.10%
2023 11.43% 10.96% -5.21% 14.16% 33.80%
2022 -13.02% -24.49% -1.91% -5.41% -39.06%
2021 -2.35% 9.65% -0.06% 5.55% 12.94%
2020 -7.20% 41.99% 21.17% 16.56% 86.10%
2019 - 4.43% -8.30% 13.03% 15.67%

Growth of $10,000 as of 01/31/2024

NAV HISTORICAL PRICES

Date Net Asset Value

Portfolio

Portfolio

Portfolio Positioningas of 12/31/2023

  • Our view is that the pressure on stock market valuations from the post-pandemic inflation surge and the U.S. Federal Reserve’s aggressive tightening is nearing an end, removing a major headwind for innovation stocks. While better than feared economic growth in the United States has lowered the probability of Fed rate cuts in the near term, we still believe many of the drivers of falling core inflation remain intact.
  • Additionally, in an environment of moderate economic growth, we believe secular growth companies are positioned to outperform as their expanding markets, coupled with market-share gains, should allow continued strong compounding growth - which stands out relative to other parts of the market in a slowing economy.
  • We remain focused on companies with improving operating and price momentum, with an emphasis on accelerating 2024 revenue and earnings growth. We are finding ample opportunities within emerging, as well as established, secular growth trends. These include, but are not limited to, the Artificial Intelligence revolution, groundbreaking advances in medical treatments (i.e., GLP-1), and a sustained improvement in the structural growth rate of the industrial complex due to the impact of reshoring and post Covid supply chain strategy. As always, there are macro risks to consider. But with sub-4% unemployment, improving wages, strong fiscal spending, we believe the prospects of a ‘hard landing’ continue to fade.

Fees & Expenses

Fees & Expenses

Sales Charge Schedule as of 02/28/2024

  Sales Charge Dealer's Concession Prices at Breakpoint
Less than $50,000 5.75% 5.00% $29.19
$50,000 to $99,999 4.75% 4.00% $28.88
$100,000 to $249,999 3.95% 3.25% $28.64
$250,000 to $499,999 2.75% 2.25% $28.29
$500,000 to $999,999 1.95% 1.75% $28.06
$1,000,000 to $5,000,000 0.00% 1.00% $27.51

EXPENSE RATIOas of 01/31/2024

Fund Gross Expense Ratio Fund Net Expense Ratio
1.54% 1.05%

Fund Documents

Fund Documents

0Documents selected
Portfolio Holdings 1Q
Publish Date:11/03/2015
Portfolio Holdings 3Q
Publish Date:11/03/2015
Summary Prospectus
Publish Date:11/03/2015
Statutory Prospectus
Publish Date:11/03/2015
SAI
Publish Date:11/03/2015
Annual Report
Publish Date:11/03/2015
Semi-Annual Report
Publish Date:11/03/2015
Fact Sheet
Publish Date:11/03/2015

To order literature visit full website

You may add to your cart by selecting quantities in each row below.

No rows selected. Please Go back and select at least one fund document

 
Quantity
Quantity
Remove
Remove

Select funds to run a Morningstar Hypothetical Report.

    Please confirm your literature shipping address

    Please review the address information below and make any necessary changes.

    All literature orders will be shipped to the address that you enter below. This information can be edited at any time.

    Current Literature Shipping Address

    * Required field